Enterprise Value
$1.34 B
-$11.29 M-0.84%
29 min ago
Summary
- As of March 10, 2025, CLDX enterprise value is $1.34 billion, with a fall of -$11.29 million (-0.84%) during the most recent trading day.
- Over the past year, CLDX enterprise value has dropped by -$1.78 billion (-57.11%).
- CLDX enterprise value is now -58.92% below its all-time high of $3.25 billion.
Performance
CLDX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CLDX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -0.8% | -0.8% | -0.8% |
| 1 m1 month | -4.8% | -4.8% | -4.8% |
| 3 m3 months | -22.2% | -22.0% | -22.1% |
| 6 m6 months | -51.5% | -51.2% | -51.2% |
| ytdytd | -19.1% | -18.8% | -18.8% |
| 1 y1 year | -57.1% | -56.8% | -57.2% |
| 5 y5 years | +4364.3% | +3528.2% | +827.6% |
CLDX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.8% | $1.26 B | +6.1% | |
| 3 m | 3-month | $1.83 B | -27.1% | $1.26 B | +6.1% |
| 6 m | 6-month | $2.91 B | -54.1% | $1.26 B | +6.1% |
| 1 y | 1-year | $3.12 B | -57.1% | $1.26 B | +6.1% |
| 3 y | 3-year | $3.25 B | -58.9% | $936 M | +42.8% |
| 5 y | 5-year | $3.25 B | -58.9% | $9.61 M | >+9999.0% |
| alltime | all time | $3.25 B | -58.9% | $1.67 M | >+9999.0% |
Celldex Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.34 B(-19.1%) |
| 2024 | $1.65 B(-24.4%) |
| 2023 | $2.18 B(+5.1%) |
| 2022 | $2.08 B(+17.4%) |
| 2021 | $1.77 B(+170.8%) |
| 2020 | $653.50 M(+2058.7%) |
| 2019 | $30.27 M(+161.8%) |
| 2018 | $11.56 M(-96.7%) |
| 2017 | $353.11 M(-8.1%) |
| 2016 | $384.17 M(-74.0%) |
| 2015 | $1.48 B(-8.2%) |
| 2014 | $1.61 B(-19.3%) |
| 2013 | $1.99 B(+376.0%) |
| 2012 | $418.30 M(+253.9%) |
| 2011 | $118.19 M(-2.8%) |
| 2010 | $121.60 M(+33.7%) |
| 2009 | $90.96 M(+12.3%) |
| 2008 | $81.02 M(+151.7%) |
| Date | Value |
|---|---|
| 2007 | $32.19 M(-49.0%) |
| 2006 | $63.13 M(-46.5%) |
| 2005 | $118.09 M(+0.6%) |
| 2004 | $117.43 M(-25.2%) |
| 2003 | $157.05 M(+264.3%) |
| 2002 | $43.11 M(-78.4%) |
| 2001 | $199.71 M(-41.8%) |
| 2000 | $343.00 M(+224.3%) |
| 1999 | $105.77 M(+57.6%) |
| 1998 | $67.10 M(+12.3%) |
| 1997 | $59.74 M(+202.5%) |
| 1996 | $19.75 M(-60.5%) |
| 1995 | $49.94 M(+40.6%) |
| 1994 | $35.52 M(-65.9%) |
| 1993 | $104.17 M(+30.2%) |
| 1992 | $80.03 M(-34.0%) |
| 1991 | $121.33 M(+483.7%) |
| 1990 | $20.79 M |
FAQ
- What is Celldex Therapeutics enterprise value?
- What is the all time high enterprise value for Celldex Therapeutics?
- What is CLDX enterprise value year-to-date change?
- What is Celldex Therapeutics enterprise value year-on-year change?
What is Celldex Therapeutics enterprise value?
The current enterprise value of CLDX is $1.34 B
What is the all time high enterprise value for Celldex Therapeutics?
Celldex Therapeutics all-time high enterprise value is $3.25 B
What is CLDX enterprise value year-to-date change?
Celldex Therapeutics enterprise value has changed by -$315.09 M (-19.08%) since the beginning of the year
What is Celldex Therapeutics enterprise value year-on-year change?
Over the past year, CLDX enterprise value has changed by -$1.78 B (-57.11%)